Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies

Background:The PI3K/AKT/P70S6K pathway is an attractive therapeutic target in ovarian and uterine malignancies because of its high rate of deregulation and key roles in tumor growth. Here, we examined the biological effects of MSC2363318A, which is a novel inhibitor of AKT1, AKT3, and P70S6K. Method...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Natl Cancer Inst
Prif Awduron: Previs, Rebecca A., Armaiz-Pena, Guillermo N., Ivan, Cristina, Dalton, Heather J., Rupaimoole, Rajesha, Hansen, Jean M., Lyons, Yasmin, Huang, Jie, Haemmerle, Monika, Wagner, Michael J., Gharpure, Kshipra M., Nagaraja, Archana S., Filant, Justyna, McGuire, Michael H., Noh, Kyunghee, Dorniak, Piotr L., Linesch, Sarah L., Mangala, Lingegowda S., Pradeep, Sunila, Wu, Sherry Y., Sood, Anil K.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2017
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059189/
https://ncbi.nlm.nih.gov/pubmed/28376174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw296
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg